Form 8-K INCYTE CORP For: Jun 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
June 22, 2026 7:53 AM EDTIncyte Corporation (NASDAQ: INCY) has reached a settlement with the Centers for Medicare & Medicaid Services (CMS) over a dispute regarding Medicaid rebate rules applied to its drug Opzelura (ruxolitinib) cream, according to a company statement.
Under the agreement, CMS will not classify... More
